Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Magnetic resonance imaging (MRI) enhancement via T1 relaxation refers to the use of physical and chemical principles to increase image contrast in MRI scans by manipulating the longitudinal relaxation time, known as T1. This process is central to many clinical MRI applications, particularly for detecting and characterizing pathological changes in tissues. It relies on differences in T1 relaxation times between tissues, which can be further enhanced by using contrast agents, primarily paramagnetic metal chelates like gadolinium-based agents, to shorten local T1 times and increase signal intensity on T1-weighted images.
Shortening of T1 relaxation time in tissues, leading to increased signal intensity on T1-weighted images.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Magnetic Resonance Imaging Enhancement (via T1 Relaxation) (T1 MRI Enhancement).